Skip to main content

Abstract

Objective:

More knowledge is needed about whether personal recovery, as defined by the CHIME framework (connectedness, hope, identity, meaning and purpose, and empowerment), is considered important by service users with psychosis. This study examined the importance of personal recovery for a large, heterogeneous group of service users with psychosis and their perceived support from clinicians for personal recovery.

Methods:

This cross-sectional study used baseline data from 321 service users with psychosis from 39 clinical units across Norway. The INSPIRE Measure of Staff Support for Personal Recovery (based on CHIME) was used to examine personal recovery and perceived support provided for recovery. Twenty support-for-recovery items were each rated on importance (yes or no) and on the extent of support received (5-point scale). Bivariate and multiple linear regression models assessed variables associated with rated importance and support.
Results: Most service users rated personal recovery items as important, regardless of their symptomatology and functioning. Previous experience with Illness Management and Recovery, knowledge about coping with stress and illness, and having a plan for early detection and prevention of relapse were significantly associated with higher perceived support. Higher self-reported depressive symptoms, lower score on the Global Assessment of Functioning symptom subscale, and male sex were significantly associated with less perceived support.

Conclusions:

Most service users with psychosis found personal recovery important, regardless of symptomatology and functioning, which has implications for clinical practice and provides empirical evidence that recovery-oriented treatments are relevant for most service users with psychosis in various mental health services.

HIGHLIGHTS

This study examined the importance of personal recovery for a large and heterogeneous group of service users with psychosis and their perceived support from mental health clinicians for personal recovery.
Most participants rated personal recovery as important, regardless of their level of symptoms and functioning.
Previous experience with Illness Management and Recovery was significantly associated with higher perceived support for recovery, whereas high levels of general symptoms and depression were significantly associated with less perceived support.
The findings have implications for clinical practice, providing empirical evidence that recovery-oriented treatments are relevant for most service users with psychosis in various mental health services.
Personal recovery refers to changes in one’s attitude to life and illness, with emphasis on hope and the establishment of a meaningful life (1–3). Connectedness, hope, identity, meaning and purpose, and empowerment have been identified as key themes in the personal recovery concept—and have provided the acronym CHIME (4). Personal recovery has been contrasted with clinical recovery, where symptom reduction and increased functioning are the main treatment focus (2).
There has been debate over the relationship between personal recovery and the traditional clinical recovery goal of reduced symptomatology and improved functioning (5). This has important clinical implications. Some studies have shown that people with psychosis can participate in working toward personal recovery regardless of their clinical and functional competence (6), whereas others have shown that service users with more clinical symptoms and a lower functioning level prefer clinical recovery goals, such as reducing symptoms and confusion (7). Some have argued that personal recovery is more of a self-realization concept, in accordance with Maslow’s pyramid (8, 9), and that for some service users, more basic needs must be met before self-realization can occur (10, 11). Because CHIME is widely endorsed in the recovery literature (12), more knowledge about the applicability of the framework is needed. An important step toward increased knowledge is to clarify whether personal recovery, as conceptualized by the CHIME framework, is considered relevant to most people with psychosis. A better understanding of this issue can help inform mental health services and the development of recovery-oriented practices. A few studies have used qualitative data to investigate the applicability of the CHIME framework, and results have supported the category structure (13, 14) but have also suggested an expanded conceptualization of recovery, in which experienced difficulties are more prominent (14). However, no studies have quantitatively examined the applicability of the framework.
Support of and focus on personal recovery have become increasingly important aspects of mental health services in many countries (5, 15). Lately, several recovery-oriented interventions have been developed and implemented in mental health systems internationally (16). For example, Illness Management and Recovery (IMR) treatment (17) aims to improve the ability of individuals with severe mental illness to better manage their illness in areas such as symptomatology, functioning, knowledge, progress toward goals, and hope (18, 19). However, one of the biggest obstacles to the implementation of recovery-oriented practices is the lack of knowledge about how recovery can be best supported (20). More knowledge about factors associated with perceived support for personal recovery is important for improving treatment and health service development and bridging the gap between the personal recovery vision and clinical practice.
This cross-sectional study aimed to answer the following research questions: Is personal recovery as defined by the CHIME framework considered important for service users with psychosis? Are there any differences between service users with different levels of rated importance? How much perceived support for personal recovery do the service users receive? And what covariates are associated with perceived support?

Methods

Design

The study had a cross-sectional design, with baseline data from a Norwegian research project—a randomized trial of implementation of the Norwegian national clinical guidelines for treatment of psychosis (ClinicalTrials NCT03271242: “A pairwise randomized study on implementation of guidelines and evidence based treatments of psychoses”). The study was approved by the Regional Committee for Medical and Health Research Ethics (REK Sørøst B 2015/2169), following the principles in the Declaration of Helsinki.

Sample and Setting

Inclusion criteria were mental health service user, age ≥16, and ICD-10 diagnosis of psychosis (F20–29) (21). Exclusion criteria were an inability to understand and answer the questionnaires in Norwegian. A total of 325 service users participated in the project. Service users (N=4) with missing data on the INSPIRE measure were excluded from analysis in this study. A total of 39 clinical units and hospital departments with outpatient clinics, day units, mobile teams, and inpatient wards from six health authorities across Norway participated, including three university hospitals.

Measures

Service user–rated measures.

The INSPIRE Measure of Staff Support for Personal Recovery was used to examine the importance of personal recovery and to assess experienced support from a mental health clinician. The INSPIRE is a 27-item self-report questionnaire that measures perceived staff support for personal recovery (22). It consists of two subscales: support (20 items) and relationship (7 items). The relationship subscale was not completed in this study. The support items cover five domains: connectedness, hope, identity, meaning and purpose, and empowerment, which were identified through a systematic review and given the acronym CHIME (4). Participants first rate each support item for whether they consider it important for their recovery (e.g., “An important part of my recovery is: Feeling supported by other people”—yes or no). If yes, participants rate the extent of support they experience from their mental health clinician (“I feel supported from my worker with this”) on that item on a 5-point Likert scale (0, not at all; 1, not much; 2, somewhat; 3, quite a lot; and 4, very much).
The number of “yes-important” responses was used as the dependent variable to examine whether personal recovery was considered important and whether any differences existed between service users with different levels of rated importance. The support score was used as the dependent variable to examine perceived support for personal recovery and covariates associated with perceived support.
The Behavior and Symptom Identification Scale (BASIS-24) is a brief self-report measure of six domains of mental well-being and functioning, with good validity and reliability for assessing mental health status from a service user perspective (23, 24). Two of the six domains were used. The depression-functioning domain was included as a measure of the level of participants’ depressive symptoms. The substance abuse domain was also included and was transformed into a dichotomous variable (substance abuse versus no substance abuse). Abuse was defined as a score of 3 (often) or 4 (always) on any of the items in the domain. Item 22 (“Did anyone talk to you about your drinking and drug use?”) was excluded because it was considered irrelevant. Subdomain scores were calculated as described in the BASIS-24 instruction guide (25), providing a score between 0 and 4, with higher scores indicating more severe problems.
Participants’ satisfaction with life was assessed with one item from the Manchester Short Assessment of Quality of Life (MANSA) (26). “How satisfied are you with your life as a whole?” was rated on a 7-point scale (1, couldn’t be worse; 7, couldn’t be better).
Participants also rated six statements about their overall experience with getting help to manage their lives and their illness for the past 6 months. The six statements pertaining to overall experience were named as follows. Setting goals: “I have been well trained in setting goals and working to achieve them.” Increased knowledge: “I have gained useful knowledge about stress, vulnerability, and social support.” Coping: “I have gained useful knowledge about coping with stress and illness.” Health service use: “I have gained useful knowledge about how to use health services better.” Medication: “I have gained useful knowledge about the medicines I use.” Early detection and prevention of relapse: “I have prepared a plan for the early detection of any signs of aggravation, and what should be done then.” The questions were rated on a 5-point scale (1, strongly disagree; 5, strongly agree), with an additional option of answering “not relevant.”
The participants also reported whether they had participated in IMR groups during the past 6 months (yes or no). This variable was named IMR experience.

Clinician-rated measures.

The Clinical Global Impressions Scale (CGI) was originally developed for use in National Institute of Mental Health–sponsored clinical trials (27). This study included the CGI severity component (CGI-S), in which clinicians rate the severity of service users’ mental illness in the past 7 days on a 7-point scale (1, normal, not at all ill; 7, among the most extremely ill service users) (28).
The Global Assessment of Functioning Scale (GAF) is a standardized assessment of impairment caused by mental factors (29) in which clinicians rate the level of functioning and severity of service users’ symptoms on a scale from 1 to 100. Lower scores indicate more severe symptoms and lower levels of functioning. The split version of the scale used in this study has two subscales: symptom (GAF-S) and functioning (GAF-F) (30).
First, we identified covariates on service user characteristics (age, gender, ethnicity, community treatment order status, and mental health care history), service user–rated measures (depression-functioning, satisfaction with life, and substance abuse), and clinician-rated measures (GAF-S, GAF-F, and CGI-S). These were chosen on the basis of prior research as described above and were factors that we hypothesized might affect or mediate the outcomes in the study.
Second, because of the small part of the variation explained by these variables in the regression models, we included data on health service characteristics, such as the six statements pertaining to overall experience (overall experience) and IMR experience variables, to determine whether this explained more of the outcome. We hypothesized that experience with IMR and related recovery themes (overall experience) might increase both level of importance and perceived support.

Procedures

Clinicians at participating clinical units recruited service users and performed the clinical ratings. Questionnaires were administered to service users by the secretary or other personnel at the clinics. Service users were provided a place to sit to fill out the questionnaires or took the questionnaire home with them. When the service user was finished, the questionnaire was put in an envelope, which was closed and returned to the clinic. Recruitment began in June 2016. Eligible service users already in contact with the clinic at the time and newly referred service users assessed to have psychosis were asked to participate. Recruitment continued until March 2017. Only participants who gave written informed consent were included.

Analysis

To assess the characteristics associated with number of yes-important answers and with the total support score, bivariate and multiple linear regression models were estimated. First, models with participant characteristics (age, gender, ethnicity, community treatment order status, and mental health care history), participant-rated measures (depression-functioning, satisfaction with life, and substance abuse), and clinician-rated measures (GAF-S, GAF-F, and CGI-S) were estimated. Next, covariates on service users’ overall experiences in managing their life and illness (overall experience statements) and whether they had participated in IMR (IMR experience) were added. Because participants were recruited to the study by different units, a hierarchical structure (cluster effect on unit level) could have been present in the data. Assessment by an intraclass correlation coefficient (ICC) found that there was essentially no cluster effect in outcome variables (ICC=0.001 for number of yes-important answers and ICC=0.01 for support score). Hence, no adjustment for within-unit correlations was needed. Correlation analysis did not identify any multicollinearity issues among covariates. Residual diagnostics did not show any significant deviations from linear regression model assumptions. Both bivariate and multiple models were estimated for cases with no missing values on covariates. Results with p values below 0.05 were considered statistically significant. The analyses were performed with SPSS, version 25.
Imputation of missing values on the GAF (N=40), the MANSA (N=8), and the overall experience (N=25) scales was performed by first generating the empirical distribution for each variable. A random number was drawn from that distribution and used to replace the missing value. The process was repeated until all missing values were imputed. Missing values on demographic variables were not imputed.

Results

Sample Characteristics

The characteristics of the 321 participants are shown in Table 1.
TABLE 1. Characteristics of 321 participants with psychosis
CharacteristicMissingN%
Female113341
Ethnicity5  
 Norwegian 27788
 Other 3912
Age (M±SD)a1140±12.797
Diagnosis25  
 Schizophrenia 15853
 Schizoaffective disorder 5920
 Other 7927
GAF subscale (M±SD)b   
 Symptom 53±13100
 Functioning 51±11.3100
Under a community treatment order74213
Time in mental health care14  
 <6 months 207
 6–23 months 289
 2–5 years 5016
 6–10 years 6421
 >10 years 14547
Education11  
 Did not complete primary school 93
 Primary school 9631
 Upper secondary school 8126
 Vocational education 5317
 Higher education 6220
 Other 93
Satisfaction with life (M±SD)c04.5±1.4 
Overall experience (M±SD)d   
 Setting goals13.4±1.1 
 Increased knowledge23.3±1.2 
 Coping23.3±1.1 
 Health service use13.2±1.1 
 Medication13.5±1.1 
 Early detection and prevention of relapse23.1±1.3 
Illness Management and Recovery experience49831
a
Range, 16–77.
b
The Global Assessment of Functioning (GAF) split version assessed symptom severity and psychosocial functioning. Possible scores range from 0–100, with higher scores indicating less severe symptoms and better functioning. Scores in the sample ranged from 26 to 90 on the symptom subscale and 20 to 85 on the functioning subscale.
c
Assessed with one item from the Manchester Short Assessment of Quality of Life. Possible scores range from 1 to 7, with higher scores indicating a greater satisfaction.
d Possible ratings on receipt of help to manage life and illness in the six indicated areas range from 1 to 5, with higher ratings indicating more help.

Importance of Personal Recovery

The 321 participants rated the 20 INSPIRE support items as important or not important to their recovery. The percentages who gave a rating of important to each item ranged from 66% to 91% (Table 2). Ten (3%) participants rated all 20 items as not important. A total of 167 participants (52%) gave an “important” rating to between 17 and 20 items. Figure 1 further illustrates participants’ ratings of items as important to personal recovery.
FIGURE 1. Number of items on support for personal recovery rated as important by 321 study participants with psychosisa
aItems were from the INSPIRE Measure of Staff Support for Personal Recovery.
TABLE 2. Ratings by participants with psychosis of items related to support for personal recovery from the INSPIRE Measure of Staff Support for Personal Recovery
 Importance to recoveryPerceived support from mental health clinician
 NotNotNotQuiteVery
Domain and itemimportantImportantRatingaat allmuchSomewhata lotmuch
N%N%MSDN%N%N%N%N%
Connectedness                
 Feeling supported by other people3711284892.83.851<11667828125446422
 Having positive relationships with other people309290912.73.89412287325140485118
 Having support from people who use services9831217692.61.9252126843978363817
 Feeling part of my community7423246772.62.994233136125103424518
Hope                
 Feeling hopeful of my future5818259822.611.02732510873383325722
 Believing I can recover4012280882.79.96621668029107387125
 Feeling motivated to make changes6821250792.621.0294229732996385020
 Having hopes and dreams for the future5116268842.621.06623413803083316524
Identity                
 Feeling I can deal with stigma9130214702.271.121992713743466312813
 Feeling good about myself7022247782.59.98522611833485344819
 Having my spiritual beliefs respected9932215682.61.9673167673189413617
 Having my ethnic, cultural, racial identity respected10534207662.711.11115168532670345727
Meaning and purpose                
 Understanding my mental health experiences6320251802.73.10831876526102415823
 Doing things that mean something to me3411285892.74.91312487526125445820
 Rebuilding my life after difficult experiences5216264842.78.9852197742898376826
 Having a good quality of life4013278872.69.99622598230102376323
Empowerment                
 Feeling in control of my life5517262832.701.038326106324104406123
 Being able to manage my mental health3712281882.80.94412077226117426824
 Trying new things10432216682.53.10522512773669324018
 Building on my strengths4614271862.61.98932078933102385119
a
Rated on a 5-point Likert scale (0, not at all; 4, very much).

Differences Between Service Users With Different Levels of Rated Importance

A multiple linear regression model examined characteristics associated with ratings of important (Table 3). The model explained 4.8% of the total variation in the number of ratings of important. When covariates on service users’ overall experience with managing their life and illness for the past 6 months (the six statements) and information on participation in IMR groups for the past 6 months (IMR experience) were included, the model explained 8.1% of the total variation. No significant associations were found in the multiple linear regression model.
TABLE 3. Linear regression model of variables as associations of the number of items rated as important to personal recovery by 275 participants with psychosisa
 Bivariate modelMultiple model
VariableCoefficient95% CIpCoefficient95% CIp
Global Assessment of Functioning symptom subscale–.01–.06, .03.515–.02–.09, .04.471
Global Assessment of Functioning functioning subscale–.00–.05, .05.862–.01–.08, .06.799
Clinical Global Impressions Scale severity component–.16–.55, .24.436–.13–.64, .38.622
Service user–rated depression-functioning–.62–1.22, –.03.040–.56–1.34, .23.165
Service user–rated satisfaction with life.29–.12, .69.161–.14–.64, .37.596
Age.02–.03, .06.410.03–.03, .08.368
Female (reference: male)1.00–.12, 2.13.081.71–.51, 1.93.252
Other ethnicity (reference: Norwegian)–.10–1.84, 1.65.915–.42–2.29, 1.45.660
Under community treatment order (reference: no).84–.78, 2.46.3071.00–.74, 2.74.259
Time in mental health care (reference: >10 years)      
 <6 months–.29–2.67, 2.09.812.49–2.05, 3.03.705
 6–23 months.50–1.59, 2.59.6371.26–.97, 3.49.267
 2–5 years1.09–.49, 2.67.1771.42–.35, 3.19.116
 6–10 years–.83–2.33, .66.273–.61–2.28, 1.05.469
Substance abuse (reference: no)–.84–2.46, .78.308–.24–2.01, 1.53.789
Overall experience      
 Setting goals.51–.01, 1.04.054.34–.34, 1.02.325
 Increased knowledge.33–.15, .81.173.11–.78, 1.00.806
 Coping.30–.22, .81.255–.24–1.13, .66.216
 Health service use.06–.46, .57.831–.42–1.10, .25.057
 Medication.60.09, 1.11.021.58–.02, 1.17.253
 Early detection and prevention of relapse.38–.07, .83.100.33–.24, .90.617
Illness Management and Recovery experience (reference: no)–.53–1.76, .70.400–.35–1.73, 1.03.617
a
The final sample was reduced to 275 because of missing values.

Support for Personal Recovery

Participants rated the level of support they had experienced from their mental health clinician in terms of the 20 INSPIRE support items. The ratings per item ranged from 2.27 to 2.83 (Table 2), showing that, on average, the service users reported levels of support from somewhat (rating of 2) to quite a lot (rating of 3).
A multiple linear regression model examined characteristics associated with experienced support (Table 4). The model explained 14.8% of the total variation in experienced support. When covariates on service users’ overall experience with managing their life and illness for the past 6 months (the six statements) and information on participation in IMR groups for the past 6 months (IMR experience) were included, the multiple linear regression model explained 31.1% of the total variation in experienced support. In the multiple model, lower GAF-S score, higher depression-functioning score, and male sex were significantly associated with lower levels of perceived support. Also, higher scores on the coping statement (“I have gained useful knowledge about coping with stress and illness”) and the statement about early detection and prevention of relapse (“I have prepared a plan for the early detection of any signs of aggravation, and what should be done then”) were significantly associated with higher perceived support, as was having participated in IMR groups during the past 6 months (IMR experience).
TABLE 4. Linear regression model of variables as associations of the sum of ratings of perceived support for personal recovery by 264 participants with psychosisa
 Bivariate modelMultiple model
VariableCoefficient95% CIpCoefficient95% CIp
Global Assessment of Functioning symptom subscale.19.03, .35.021.22.01, .43.039
Global Assessment of Functioning functioning subscale.23.04, .42.017–.06–.29, .17.617
Clinical Global Impressions Scale severity component–.93–2.41, .55.218.88–.77, 2.52.295
Service user–rated depression-functioning–4.82–7.01, –2.64<.001–3.79–6.37, –1.21.004
Service user–rated satisfaction with life2.751.27, 4.22<.001–.21–1.85, 1.43.800
Age.12–.05, .28.180.07–.11, .24.473
Female (reference: male)6.862.69, 11.03.0015.151.18, 9.11.011
Other ethnicity (reference: Norwegian)2.75–3.78, 9.28.4082.87–3.23, 8.96.355
Under community treatment order (reference: no).65–5.35, 6.65.8301.57–4.03, 7.17.582
Time in mental health care (reference: >10 years)      
 <6 months–5.35–14.40, 3.70.245–3.28–11.62, 5.05.438
 6–23 months–6.04–13.91, 1.84.133–2.99–10.29, 4.30.420
 2–5 years–3.34–9.20, 2.53.263–3.06–8.77, 2.66.293
 6–10 years–1.07–6.75, 4.62.712.21–5.48, 5.52.994
Substance abuse (reference: no)–3.19–9.17, 2.80.2954.33–1.39, 10.05.137
Overall experience      
 Setting goals5.673.81, 7.54<.0011.71–.51, 3.93.131
 Increased knowledge4.853.17, 6.52<.001.06–2.82, 2.93.969
 Coping6.334.58, 8.08<.0013.911.03, 6.80.008
 Health service use4.392.56, 6.22<.001.86–1.36, 3.07.446
 Medication3.621.74, 5.49<.001.55–1.37, 2.47.572
 Early detection and prevention of relapse4.552.93, 6.17<.0012.13.26, 4.00.025
Illness Management and Recovery experience (reference: no).09–4.55, 4.72.9714.62.08, 9.16.046
a
The final sample was reduced to 264 because of missing values.

Discussion

This study showed that most service users with psychosis considered personal recovery, as operationalized with the CHIME framework, to be important. The study found no differences between service users who rated personal recovery as less important and those rating it as more important. Overall, service users experienced only moderate support for personal recovery from their mental health clinician. Higher self-reported depressive symptoms, lower GAF-S score, and male sex were significantly associated with less perceived support. Having participated in IMR groups, having gained knowledge about coping with stress and illness, and having a plan for early detection and prevention of relapse for the past 6 months were significantly associated with higher perceived support.
The main finding was that the great majority of a large, heterogeneous group of service users with psychosis across several clinical units reported that personal recovery was important to them, regardless of age, ethnicity, symptomatology, functioning, community treatment order status, and time in mental health care. This finding has implications for clinical practice, providing empirical evidence that recovery-oriented treatments are relevant for most service users with psychosis in various mental health services.
However, although the great majority of participants reported personal recovery to be of high importance, they experienced only a moderate degree of personal recovery support from their mental health clinician. Several factors can influence the level of experienced support for recovery, not the least being the degree to which various clinicians and various mental health units are recovery oriented. Our findings show that previous experience with IMR and related themes, such as knowledge about coping with stress and illness and having a plan for early detection and prevention of relapse, were significantly associated with higher perceived support. This suggests that recovery-oriented treatments such as IMR and related themes may be effective in helping people feel supported in their process of personal recovery, a result in line with a recent meta-analysis showing greater improvement in personal recovery outcomes when service users were involved in recovery-oriented mental health treatment versus usual care or other types of treatment (31). Future research should examine perceived support and IMR treatment in relation to the different CHIME domains.
In addition, we found that higher self-reported depressive symptoms, lower GAF-S score, and male sex were significantly associated with less perceived support. This finding is of clinical importance. That is, it is important not to be blinded by high levels of general symptoms or depression, because these service users nevertheless believe that personal recovery is important. Although we cannot draw conclusions regarding causality among these associations, our results point to the importance of providing support for personal recovery, even among service users with high levels of general symptoms and depression. Future research should examine how patterns of importance ratings change over time and how perceptions of support are influenced by treatment.
Previous research has shown that affective symptoms seem to be more closely linked than psychotic symptoms to personal recovery and related themes, such as quality of life (5, 32, 33). Our finding that a higher level of self-reported depression was related to less perceived support underlines the important notion of an association between affective symptoms and personal recovery among service users with psychosis.
A major strength of this study was the broad group of participants with psychosis and the many different units that participated, which allowed us to gain information that can be generalized to a range of mental health services for service users with psychosis. A limitation of the study was the lack of data on the representativeness of the sample. Because participants were not randomly selected, they may not accurately represent the overall Norwegian population of individuals with psychosis. Other important limitations were the cross-sectional nature of the study, which prevented conclusions regarding causality, and that interrater reliability between the GAF scales and the CGI scale was not assessed.

Conclusions

This study showed that the great majority of a large, heterogeneous group of service users with psychosis across several clinical units reported that personal recovery was important for them, regardless of age, ethnicity, symptomatology, functioning, community treatment order status, and time in mental health care. This finding has implications for clinical practice, providing empirical evidence that recovery-oriented treatments are relevant for most service users with psychosis in various mental health services. Recovery-oriented treatments such as IMR, and related themes, such as help for coping with stress and illness and having a plan for early detection and prevention of relapse, appeared to help people with psychosis feel supported by clinicians in their personal recovery process. Specific attention should be given to service users with high levels of general symptoms and depression, because these service users experienced less support for personal recovery, even though personal recovery was equally important for them.

Acknowledgments

Dr. Slade acknowledges support from the Center for Mental Health and Substance Abuse, University of South-Eastern Norway, and the Nottingham Biomedical Research Centre, National Institute for Health Research.

References

1.
Anthony WA: Recovery from mental illness: the guiding vision of the mental health service system in the 1990s. Psychosoc Rehabil J 1993; 16:11–23
2.
Slade M, Amering M, Oades L: Recovery: an international perspective. Epidemiol Psichiatr Soc 2008; 17:128–137
3.
Resnick SG, Fontana A, Lehman AF, et al: An empirical conceptualization of the recovery orientation. Schizophr Res 2005; 75:119–128
4.
Leamy M, Bird V, Le Boutillier C, et al: Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. Br J Psychiatry 2011; 199:445–452.
5.
Van Eck RM, Burger TJ, Vellinga A, et al: The relationship between clinical and personal recovery in patients with schizophrenia spectrum disorders: a systematic review and meta-analysis. Schizophr Bull 2018; 44:631–642.
6.
Chan RCH, Mak WWS, Chio FHN, et al: Flourishing with psychosis: a prospective examination on the interactions between clinical, functional, and personal recovery processes on well-being among individuals with schizophrenia spectrum disorders. Schizophr Bull 2018; 44:778–786.
7.
Rosenheck R, Stroup S, Keefe RS, et al: Measuring outcome priorities and preferences in people with schizophrenia. Br J Psychiatry 2005; 187:529–536.
8.
Maslow AH: A theory of human motivation. Psychol Rev 1943; 50:370–396
9.
Henwood BF, Derejko KS, Couture J, et al: Maslow and mental health recovery: a comparative study of homeless programs for adults with serious mental illness. Adm Policy Ment Health Ment Health Serv Res 2015; 42:220–228.
10.
Clarke S, Oades LG, Crowe TP: Recovery in mental health: a movement towards well-being and meaning in contrast to an avoidance of symptoms. Psychiatr Rehabil J 2012; 35:297–304.
11.
Lofthus AM, Westerlund H, Bjørgen D, et al: Recovery concept in a Norwegian setting to be examined by the assertive community treatment model and mixed methods. Int J Ment Health Nurs 2018; 27:147–157.
12.
van Weeghel J, van Zelst C, Boertien D, et al: Conceptualizations, assessments, and implications of personal recovery in mental illness: a scoping review of systematic reviews and meta-analyses. Psychiatr Rehabil J 2019; 42:169–181.
13.
Bird V, Leamy M, Tew J, et al: Fit for purpose? Validation of a conceptual framework for personal recovery with current mental health consumers. Aust N Z J Psychiatry 2014; 48:644–653.
14.
Stuart SR, Tansey L, Quayle E: What we talk about when we talk about recovery: a systematic review and best-fit framework synthesis of qualitative literature. J Ment Health 2017; 26:291–304.
15.
Schrank B, Slade M: Recovery in psychiatry. BJPsych Bull 2007; 31:321–325
16.
Slade M, Amering M, Farkas M, et al: Uses and abuses of recovery: implementing recovery-oriented practices in mental health systems. World Psychiatry 2014; 13:12–20.
17.
McGuire AB, Kukla M, Green A, et al: Illness Management and Recovery: a review of the literature. Psychiatr Serv 2014; 65:171–179.
18.
Egeland KM, Ruud T, Ogden T, et al: How to implement Illness Management and Recovery (IMR) in mental health service settings: evaluation of the implementation strategy. Int J Ment Health Syst 2017; 11:13
19.
Färdig R, Lewander T, Melin L, et al: A randomized controlled trial of the illness management and recovery program for persons with schizophrenia. Psychiatr Serv 2011; 62:606–612.
20.
Le Boutillier C, Leamy M, Bird VJ, et al: What does recovery mean in practice? A qualitative analysis of international recovery-oriented practice guidance. Psychiatr Serv 2011; 62:1470–1476.
21.
The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, World Health Organization, 1992
22.
Williams J, Leamy M, Bird V, et al: Development and evaluation of the INSPIRE Measure of Staff Support for Personal Recovery. Soc Psychiatry Psychiatr Epidemiol 2015; 50:777–786.
23.
Eisen SV, Normand S-L, Belanger AJ, et al: The revised Behavior and Symptom Identification Scale (BASIS-R): reliability and validity. Med Care 2004; 42:1230–1241.
24.
Cameron IM, Cunningham L, Crawford JR, et al: Psychometric properties of the BASIS-24 (Behaviour and Symptom Identification Scale–Revised) mental health outcome measure. Int J Psychiatry Clin Pract 2007; 11:36–43.
25.
BASIS-24 Instruction Guide. Belmont, MA, McLean Hospital, 2006
26.
Priebe S, Huxley P, Knight S, et al: Application and results of the Manchester Short Assessment of Quality of Life (MANSA). Int J Soc Psychiatry 1999; 45:7–12.
27.
Guy W: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD, US Department of Health, Education, and Welfare, Public Health Service. Alcohol, Drug Abuse, and Mental Health Administration, 1976
28.
Busner J, Targum SD: The Clinical Global Impressions Scale: applying a research tool in clinical practice. Psychiatry 2007; 4:28–37.
29.
Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Arlington, VA, American Psychiatric Association Publishing, 2013
30.
Pedersen G, Hagtvet KA, Karterud S: Generalizability studies of the Global Assessment of Functioning–split version. Compr Psychiatry 2007; 48:88–94.
31.
Thomas EC, Despeaux KE, Drapalski AL, et al: Person-oriented recovery of individuals with serious mental illnesses: a review and meta-analysis of longitudinal findings. Psychiatr Serv 2018; 69:259–267.
32.
Priebe S, Reininghaus U, McCabe R, et al: Factors influencing subjective quality of life in patients with schizophrenia and other mental disorders: a pooled analysis. Schizophr Res 2010; 121:251–258.
33.
Clausen H, Landheim A, Odden S, et al: Associations between quality of life and functioning in an assertive community treatment population. Psychiatr Serv 2015; 66:1249–1252.

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services
Psychiatric Services
Pages: 661 - 668
PubMed: 33882681

History

Received: 7 April 2020
Revised: 28 August 2020
Revision received: 28 August 2020
Accepted: 1 October 2020
Published online: 22 April 2021
Published in print: June 2021

Keywords

  1. Recovery
  2. Schizophrenia
  3. service user
  4. PROM

Authors

Details

Regina Skar-Fröding, M.Sc.
Division of Mental Health Services, Akershus University Hospital, Lørenskog, Norway (Skar-Fröding, Clausen, Ruud, Sverdvik Heiervang); Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders and Mental Health Division, Innlandet Hospital Trust, Brumunddal (Clausen); Institute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo (Šaltytė Benth, Ruud); Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway (Šaltytė Benth); Institute of Mental Health, School of Health Sciences, University of Nottingham, Nottingham, United Kingdom (Slade); Centre for Medical Ethics, Faculty of Medicine, University of Oslo, Oslo (Sverdvik Heiervang).
Hanne Kristin Clausen, M.D., Ph.D.
Division of Mental Health Services, Akershus University Hospital, Lørenskog, Norway (Skar-Fröding, Clausen, Ruud, Sverdvik Heiervang); Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders and Mental Health Division, Innlandet Hospital Trust, Brumunddal (Clausen); Institute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo (Šaltytė Benth, Ruud); Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway (Šaltytė Benth); Institute of Mental Health, School of Health Sciences, University of Nottingham, Nottingham, United Kingdom (Slade); Centre for Medical Ethics, Faculty of Medicine, University of Oslo, Oslo (Sverdvik Heiervang).
Jūratė Šaltytė Benth, Ph.D.
Division of Mental Health Services, Akershus University Hospital, Lørenskog, Norway (Skar-Fröding, Clausen, Ruud, Sverdvik Heiervang); Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders and Mental Health Division, Innlandet Hospital Trust, Brumunddal (Clausen); Institute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo (Šaltytė Benth, Ruud); Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway (Šaltytė Benth); Institute of Mental Health, School of Health Sciences, University of Nottingham, Nottingham, United Kingdom (Slade); Centre for Medical Ethics, Faculty of Medicine, University of Oslo, Oslo (Sverdvik Heiervang).
Torleif Ruud, M.D., Ph.D.
Division of Mental Health Services, Akershus University Hospital, Lørenskog, Norway (Skar-Fröding, Clausen, Ruud, Sverdvik Heiervang); Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders and Mental Health Division, Innlandet Hospital Trust, Brumunddal (Clausen); Institute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo (Šaltytė Benth, Ruud); Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway (Šaltytė Benth); Institute of Mental Health, School of Health Sciences, University of Nottingham, Nottingham, United Kingdom (Slade); Centre for Medical Ethics, Faculty of Medicine, University of Oslo, Oslo (Sverdvik Heiervang).
Mike Slade, Ph.D.
Division of Mental Health Services, Akershus University Hospital, Lørenskog, Norway (Skar-Fröding, Clausen, Ruud, Sverdvik Heiervang); Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders and Mental Health Division, Innlandet Hospital Trust, Brumunddal (Clausen); Institute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo (Šaltytė Benth, Ruud); Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway (Šaltytė Benth); Institute of Mental Health, School of Health Sciences, University of Nottingham, Nottingham, United Kingdom (Slade); Centre for Medical Ethics, Faculty of Medicine, University of Oslo, Oslo (Sverdvik Heiervang).
Kristin Sverdvik Heiervang, Ph.D.
Division of Mental Health Services, Akershus University Hospital, Lørenskog, Norway (Skar-Fröding, Clausen, Ruud, Sverdvik Heiervang); Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders and Mental Health Division, Innlandet Hospital Trust, Brumunddal (Clausen); Institute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo (Šaltytė Benth, Ruud); Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway (Šaltytė Benth); Institute of Mental Health, School of Health Sciences, University of Nottingham, Nottingham, United Kingdom (Slade); Centre for Medical Ethics, Faculty of Medicine, University of Oslo, Oslo (Sverdvik Heiervang).

Notes

Send correspondence to Ms. Skar-Fröding ([email protected]).

Funding Information

This study was funded by grant 2015106 from the South-Eastern Norway Regional Health Authority (Helse Sør-Øst). Dr. Slade acknowledges support from the Center for Mental Health and Substance Abuse, University of South-Eastern Norway, and the Nottingham Biomedical Research Centre, National Institute for Health Research.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share